Superfund Research Program
Research Support Core
Project Leader: Dean Edwards
Co-Investigators: Shixia Huang, Sung Yun Jung, Daniel Kraushaar, Nagireddy Putluri
Grant Number: P42ES027725
Funding Period: 2020-2025
Project-Specific Links
- Project Summary
Publications
2023
- Purushothaman A, Olivia-Ramirez J, Treekitkarnmongkol W, Sankaran D, Hurd MW, Putluri N, Maitra A, Haymaker C, Sen S. 2023. Differential effects of pancreatic cancer-derived extracellular vesicles driving a suppressive environment. Int J Mol Sci 24(19):14652. doi:10.3390/ijms241914652 PMID:37834100 PMCID:PMC10572854
- Thaiparambil J, Amara CS, Sen S, Putluri N, El-Zein R. 2023. Cigarette smoke condensate induces centrosome clustering in normal lung epithelial cells. Cancer Med doi:10.1002/cam4.5599 PMID:36621828 PMCID:PMC10134322
2022
- Reddy KR, Piyarathna DW, Kamal AH, Putluri V, Ravi SS, Bollag RJ, Terris MK, Lotan Y, Putluri N. 2022. Lipidomic profiling identifies a novel lipid signature associated with ethnicity-specific disparity of bladder cancer. Metabolites 12(6):doi:10.3390/metabo12060544 PMID:35736477 PMCID:PMC9230655
- Saie AE, Fu C, Grimm SL, Robertson M, Hoffman K, Putluri V, Ambati CS, Putluri N, Shivanna B, Coarfa C, Pammi M. 2022. Metabolome and microbiome multi-omics integration from a murine lung inflammation model of bronchopulmonary dysplasia. Pediatric Research 10:doi:10.1038/s41390-022-02002-1 PMID:35338351
- Thaiparambil J, Dong J, Grimm SL, Perera D, Ambati CS, Putluri V, Robertson M, Patel TD, Mistretta B, Gunaratne PH, Kim MP, Yustein JT, Putluri N, Coarfa C, El-Zein R. 2022. Integrative metabolomics and transcriptomics analysis reveals novel therapeutic vulnerabilities in lung cancer. Cancer Med doi:10.1002/cam4.4933 PMID:35676822
2021
- Coarfa C, Grimm SL, Rajapakshe K, Perera D, Lu H, Wang X, Christensen KR, Mo Q, Edwards D, Huang S. 2021. Reverse-phase protein array: technology, application, data processing, and integration. J Biomol Tech doi:10.7171/jbt.2021-3202-001 PMID:33584151 PMCID:PMC7861052 (ahead of print)
- Kaochar S, Rusin A, Foley C, Rajapakshe K, Robertson M, Skapura D, Mason C, Ruiz CB, Tyryshkin AM, Deng J, Shin JN, Fiskus W, Dong J, Huang S, Navone NM, Davis CM, Ehli EA, Coarfa C, Mitsiades N. 2021. Inhibition of GATA2 in prostate cancer by a clinically available small molecule. Endocr Relat Cancer 29(1):15-31. doi:10.1530/ERC-21-0085 PMID:34636746 PMCID:PMC8634153